Decoy Therapeutics Inc. awarded insider Gauthier Patricia G. 2,000 shares at $0 per share on Aug. 31, 2026. The transaction left her with ownership of 2,000 shares, giving investors a defined view of the insider’s reported stake after the award.
Key Highlights
- The award was recorded on Aug. 31, 2026.
- The transaction carried code A.
- Gauthier Patricia G. owned 2,000 shares after the transaction.
Decoy Therapeutics Inc. (NASDAQ: DCOY) awarded Gauthier Patricia G. 2,000 shares at $0 per share on Aug. 31, 2026. Her reported ownership after the transaction was 2,000 shares.
$0 Insider Award Leaves 2,000-Share Stake
The transaction was recorded under code A. The award involved Decoy Therapeutics shares priced at $0 per share. Gauthier Patricia G. held 2,000 shares following the transaction. The transaction date was Aug. 31, 2026.
FAQs
Q: What did Decoy Therapeutics award its insider?
A: Decoy Therapeutics awarded Gauthier Patricia G. 2,000 shares. The shares were priced at $0 per share in the reported insider transaction.
Q: What was Gauthier Patricia G.’s Decoy Therapeutics stake afterward?
A: Gauthier Patricia G. owned 2,000 Decoy Therapeutics shares after the award. The reported ownership followed the Aug. 31, 2026 transaction.
Q: When did the Decoy Therapeutics insider transaction occur?
A: The Decoy Therapeutics insider transaction occurred on Aug. 31, 2026. It was recorded under transaction code A and involved 2,000 shares.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.